Associate Professor of Medicine @yalemed @yalenephrology
Joined February 2022
- Tweets3
- Following23
- Followers73
- Likes1
Jeffrey Turner retweeted
EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022 from @NEJM #KidneyWk #Nephpearls
šš¼ nejm.org/doi/full/10.1056/NEā¦ ā at Florida, USA
@jmdnephdoc doing what he does best at #KidneyWk. Great talk on Hepatorenal Syndrome and kidney injury markers. Itās good to know there is still some value in calculating FeNa. @YaleNephrology @brewster_ursula @virmani_sar
Watch out world, @YaleNephrology is taking on POCUS!!! Hands on faculty training session with @Yale_EUS and @cmoore433 today in the Yale Sim Lab!!! @Nephronette was inspiring all of us with her skills.
